PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shaw RJ et al. – Reporting of ECS is essential in accurate prognostication, and the authors advocate that all patients with OSCC and ECS should be grouped as pN3 on the basis of their prognosis.

Related Articles

Oral cancer and polymorphism of ethanol metabolising genes
Oral Oncology, 11/12/09    Relevance Score: 70%

Quantification of betel quid chewing and cigarette smoking in oral cancer patients
Community Dentistry and Oral Epidemiology, 11/17/09    Relevance Score: 69%

Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer
International Journal of Cancer, 11/10/09    Relevance Score: 68%

Saliva as a tool for oral cancer diagnosis and prognosis
Oral Oncology, 10/21/09    Relevance Score: 68%

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09    Relevance Score: 68%

Today in ENT...keeping you current

Ear candling: A case report
The European Journal of General Practice, 12/08/09

Parathyroidectomy in the elderly population: Does age really matter
The Laryngoscope, 12/08/09

Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles
The Laryngoscope, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address